What is the Fiscal Year for KalVista Pharmaceuticals?
Date: November 13, 2026
KalVista Pharmaceuticals's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q4, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q4
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
Framingham, Massachusetts
Industry
Biotechnology Research
Stock Symbol
KALV
Website
http://kalvista.comDescription
KalVista, a company of the Chiesi Group, is a global pharmaceutical company dedicated to delivering life-changing oral therapies for people affected by rare diseases with significant unmet needs. The KalVista team discovered and developed the first and only oral on-demand treatment for hereditary angioedema (HAE) and continues to work closely with the global HAE community to improve treatment and care worldwide. As part of Chiesi Global Rare Diseases, a Chiesi Group business unit established to deliver innovative therapies and solutions for people living with rare diseases, KalVista is building on its expertise in HAE and contributing to a shared mission to help underserved rare disease communities live their most fulfilling lives.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like KalVista Pharmaceuticals and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.